These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14578677)

  • 1. The alkylating agent penclomedine induces degeneration of purkinje cells in the rat cerebellum.
    O'Reilly S; O'Hearn E; Struck RF; Rowinsky EK; Molliver ME
    Invest New Drugs; 2003 Aug; 21(3):269-79. PubMed ID: 14578677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine.
    Waud WR; Tiwari A; Schmid SM; Shih TW; Strong JM; Hartman NR; O'Reilly S; Struck RF
    Cancer Res; 1997 Mar; 57(5):815-7. PubMed ID: 9041177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a non-NMDA antagonist, GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine.
    O'Hearn E; Molliver ME
    Neuroscience; 2004; 127(2):373-83. PubMed ID: 15262328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acrylamide neuropathy. I. Spatiotemporal characteristics of nerve cell damage in rat cerebellum.
    Lehning EJ; Balaban CD; Ross JF; Reid MA; LoPachin RM
    Neurotoxicology; 2002 Sep; 23(3):397-414. PubMed ID: 12387366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline.
    O'Hearn E; Molliver ME
    Neuroscience; 1993 Jul; 55(2):303-10. PubMed ID: 8377927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calbindin D-28 and microtubule-associated protein-2: their use as sensitive immunohistochemical markers of cerebellar neurotoxicity in a regulatory toxicity study.
    Haworth R; McCormack N; Selway S; Pilling AM; Williams TC
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):419-26. PubMed ID: 16542831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancy.
    Liu G; Berlin J; Tutsch KD; Van Ummersen L; Dresen A; Marnocha R; Arzomanian R; Alberti D; Feierabend C; Binger K; Wilding G
    Clin Cancer Res; 2002 Mar; 8(3):706-11. PubMed ID: 11895899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro metabolism of penclomedine in mouse, rat, and human systems.
    Hartman NR; Leo KU; Brewer TG; Strong JM
    Drug Metab Dispos; 1998 Jun; 26(6):513-9. PubMed ID: 9616185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytarabine induced cerebellar neuronal damage in juvenile rat: correlating neurobehavioral performance with cellular and genetic alterations.
    Patel RS; Rachamalla M; Chary NR; Shera FY; Tikoo K; Jena G
    Toxicology; 2012 Mar; 293(1-3):41-52. PubMed ID: 22212197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar toxicity of phencyclidine.
    Näkki R; Koistinaho J; Sharp FR; Sagar SM
    J Neurosci; 1995 Mar; 15(3 Pt 2):2097-108. PubMed ID: 7891155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine and human in vivo penclomedine metabolism.
    Hartman NR; O'Reilly S; Rowinsky EK; Collins JM; Strong JM
    Clin Cancer Res; 1996 Jun; 2(6):953-62. PubMed ID: 9816256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of penclomedine and systemic exposure to 4-O-demethylpenclomedine in patients receiving oral and intravenous penclomedine.
    O'Reilly S; Hartman NR; Bowling KM; Rowinsky EK; Donehower RC; Collins J; Strong JM
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):223-8. PubMed ID: 11592344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic effects of somatostatin in the cerebellum and vestibular nuclei: multiple sites of action.
    Balaban CD; Severs WB
    Neurosci Res; 1991 Oct; 12(1):140-50. PubMed ID: 1684238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity.
    O'Hearn E; Molliver ME
    J Neurosci; 1997 Nov; 17(22):8828-41. PubMed ID: 9348351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumors.
    O'Reilly S; Grochow LB; Donehower RC; Chen TL; Bowling K; Hartman NR; Struck RF; Rowinsky EK
    J Clin Oncol; 1997 May; 15(5):1974-84. PubMed ID: 9164209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course and manner of Purkinje neuron death following a single ethanol exposure on postnatal day 4 in the developing rat.
    Light KE; Belcher SM; Pierce DR
    Neuroscience; 2002; 114(2):327-37. PubMed ID: 12204202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term nicotine exposure reduces Purkinje cell number in the adult rat cerebellar vermis.
    Chen WJ; Edwards RB; Romero RD; Parnell SE; Monk RJ
    Neurotoxicol Teratol; 2003; 25(3):329-34. PubMed ID: 12757829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-α (TNF-α) augments AMPA-induced Purkinje neuron toxicity.
    Bliss RM; Finckbone VL; Trice J; Strahlendorf H; Strahlendorf J
    Brain Res; 2011 Apr; 1386():1-14. PubMed ID: 21276434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-limiting neurotoxicity in a phase I study of penclomedine (NSC 388720, CRC 88-04), a synthetic alpha-picoline derivative, administered intravenously.
    Jodrell DI; Bowman A; Stewart M; Dunlop N; French R; MacLellan A; Cummings J; Smyth JF
    Br J Cancer; 1998 Mar; 77(5):808-11. PubMed ID: 9514062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.